New monospirocyclic tetrakis (aziridinyl) cyclotriphosphazene derivatives as potential antitumor drugs

A library of multisubstituted cyclotriphosphazenes – molecular scaffolds for hybrid materials

An easy pathway for the synthesis of new cyclotriphosphazene derivatives based on a Pt-catalyzed hydrosilylation process and their characterization are presented.

Structural and fluorescence properties of phenolphthalein bridged cyclotriphosphazatrienes

This study dealt with the reactions of hexachlorocyclotriphosphazatriene, N(3)P(3)Cl(6) (trimer) (1) with phenolphthalein (2) to give the phenolphthalein bridged compounds 3, 4 and 5. The phenolphthalein bridged cyclotriphosphazatriene derivatives are reported for the first time. The new compounds (3-5) are characterized by elemental analysis, mass spectrometry, UV-vis, FT-IR, (1)H, (31)P NMR and fluorescence spectroscopy. The more bridged phenolphthalein groups show the higher intensity of the absorption bands in the UV-vis spectra. Fluorescence spectrum of compound 3 shows a small band in the lower spectral range, while the spectra of compounds 4 and 5 show more intense and a band in higher spectral range.

Synthesis and in Vitro Antileukemic Activity of Some New 1,3-(Oxytetraethylenoxy)cyclotriphosphazene Derivatives

A new series of 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives bearing 2-chloroethylamine or salicylaldehyde (2-hydroxybenzaldehyde) or its Schiff base (after condensation with 2-chloroethylamine) units and having also 2-naphthyl or anthraquinone groups as cosubstituents has been synthesized. The in vitro cytotoxic activity of these compounds against a panel of four cancer cell lines has been studied. Most of the compounds exhibited antiproliferative activity in the range of the international criterion for synthetic agents (4 microg/mL) against the MOLT4, L 1210, HL-60, and P388 cell lines chosen for testing.